Paediatric liver transplantation - A review based on 20 years of personal experience

Transplant International

Volumn 17, Issue 10, 2004, Pages 562-573

  Otte, Jean Bernard ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

Children; Immunosuppression; Indications; Liver transplantation; Medical complications; Survival

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE; TACROLIMUS;

ALAGILLE SYNDROME; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTERY THROMBOSIS; BILE DUCT ATRESIA; BILIARY TRACT DISEASE; CRIGLER NAJJAR SYNDROME; FAMILIAL HYPERCHOLESTEROLEMIA; GLYCOGEN STORAGE DISEASE TYPE 1; GLYCOGEN STORAGE DISEASE TYPE 4; GRAFT FAILURE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INBORN ERROR OF METABOLISM; INFECTION; INTRAHEPATIC CHOLESTASIS; LIFE EXPECTANCY; LIVER FAILURE; LIVER GRAFT; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LIVER TUMOR; LIVING DONOR; LYMPHOPROLIFERATIVE DISEASE; MORBIDITY; NEPHROTOXICITY; NEUROLOGIC DISEASE; NEUROTOXICITY; ORGAN DONOR; OXALOSIS 1; PORTAL VEIN THROMBOSIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SIDE EFFECT; SOCIAL PSYCHOLOGY; SURGICAL TECHNIQUE; TREATMENT INDICATION; WILSON DISEASE;

CHILD; HUMANS; IMMUNOSUPPRESSION; LIFE EXPECTANCY; LIVER DISEASES; LIVER TRANSPLANTATION; LIVING DONORS; PATIENT SELECTION; PREOPERATIVE CARE; QUALITY OF LIFE;

EID: 12144258433     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00147-004-0771-y     Document Type: Review

References (125)

1. Starzl TE, Marchioro TL, Vonkaulla KN, Hermann G, Brittain RS, Waddell WR. Homotransplantation of the liver in humans. Surg Gynecol Obstet 1963; 117:659.
2. Starzl TE, Groth CG, Brettschneider L, et al. Orthotopic homotransplantation of the human liver. Ann Surg 1968; 168:392.
3. Starzl T. Memoirs of a transplant surgeon. The puzzle people. 1992; Pittsburgh, p 99.
4. Starzl TE, Klintmalm GB, Porter KA, Iwatsuki S, Schroter GP. Liver transplantation with use of cyclosporin A and prednisone. N Engl J Med 1981; 305:266.
5. Jain A, Kashyap R, Potdar S. Pediatric liver transplantation in 808 consecutive children: 18 years experience from a single center (abstract). Am J Transplant 2001; 1:288.
6. Calne R. Liver transplantation. Grune and Stratton, 1987.
7. Otte JB. Les transplantations d'organes. Presse Med 1972; 4:263.
8. Alagille D. [Liver transplantation in children. Where does it stand in 1986?] La transplantation hepatiquechez l'enfant. Qu'en est-il en 1986? Arch Fr Pediatr 1986; 43:589.
9. Otte JB, Starzl TE, Ascher N. Liver transplantation in children. Proceedings of the European Symposium. Transplant Proc 1987; 19:3229.
10. Noujaim HM, Mayer DA, Buckles JA, et al. Techniques for and outcome of liver transplantation in neonates and infants weighing up to 5 kilograms. J Pediatr Surg 2002; 37:159.
11. Evrard V, Otte JB, Sokal E, et al. Impact of surgical and immunological parameters in pediatric liver transplantation: a multivariate analysis in 500 consecutive recipients of primary grafts. Ann Surg 2004; 239:272.
12. Bismuth H, Houssin D. Reduced-sized orthotopic liver graft in hepatic transplantation in children. Surgery 1984; 95:367.
13. Broelsch CE, Emond JC, Thistlethwaite JR, Rouch DA, Whitington PF, Lichtor JL. Liver transplantation with reduced-size donor organs. Transplantation 1988; 45:519.
14. Otte JB, de Ville de Goyet j, Sokal E, et al. Size reduction of the donor liver is a safe way to alleviate the shortage of size-matched organs in pediatric liver transplantation. Ann Surg 1990; 211:146.
15. Pichlmayr R, Ringe B, Gubernatis G, Hauss J, Bunzendahl H. [Transplantation of a donor liver to 2 recipients (splitting transplantation) - a new method in the further development of segmental liver transplantation] Transplantation einer Spenderleber auf zwei Empfanger (Splitting- Transplantation) - Eineneue Methode in der Weiterentwicklung der Lebersegment transplantation. Langenbecks Arch Chir 1988; 373:127.
16. Bismuth H, Morino M, Castaing D, et al. Emergency orthotopic liver transplantation in two patients using one donor liver. Br J Surg 1989; 76:722.
17. Broelsch CE, Emond JC, Whitington PF, Thistlethwaite JR, Baker AL, Lichtor JL. Application of reduced-size liver transplants as split grafts, auxiliary orthotopic grafts, and living related segmental transplants. Ann Surg 1990; 212:368.
18. Otte JB, de Ville de Goyet J, Alberti D, Balladur P, de Hemptinne B. The concept and technique of the split liver in clinical transplantation. Surgery 1990; 107:605.
19. Otte JB, de Ville de Goyet j, Reding R, et al. Pediatric liver transplantation: from the full-size liver graft to reduced, split, and living related liver transplantation. Pediatr Surg Int 1998; 13:308.
20. Otte JB. The availability of all technical modalities for pediatric liver transplant programs. Pediatr Transplant 2001; 5:1.
21. de Ville de Goyet J. Split liver transplantation in Europe - 1988 to 1993. Transplantation 1995; 59:1371.
22. Azoulay D, Marin-Hargreaves G, Castaing D, Bismuth H. Ex situ splitting of the liver: the versatile Paul Brousse technique. Arch Surg 2001; 136:956.
23. Yersiz H, Renz JF, Farmer DG, Hisatake GM, McDiarmid SV, Busuttil RW. One hundred in situ split-liver transplantations: a single-center experience. Ann Surg 2003; 238:496.
24. de Ville de Goyet J, Otte JB. Cut-down and split liver transplantation. In: Busuttil AA, Klintmalm G (eds). Transplantation of the liver. Saunders, Philadelphia, 1996; p 481.
25. Rogiers X, Malago M, Gawad K, et al. In situ splitting of cadaveric livers. The ultimate expansion of a limited donor pool. Ann Surg 1996; 224:331.
26. Goss JA, Yersiz H, Shackleton CR, et al. In situ splitting of the cadaveric liver for transplantation. Transplantation 1997; 64:871.
27. de Ville de Goyet J, Hausleithner V, Reding R, Lerut J, Janssen M, Otte JB. Impact of innovative techniques on the waiting list and results in pediatric liver transplantation. Transplantation 1993; 56:1130.
28. Gridelli B, Spada M, Petz W, et al. Split-liver transplantation eliminates the need for living-donor liver transplantation in children with end-stage cholestatic liver disease. Transplantation 2003; 75:1197.
29. Renz JF, Emond JC, Yersiz H, Ascher NL, Busuttil RW. Split-liver transplantation in the United States: outcomes of a national survey. Ann Surg 2004; 239:172.
30. Singer PA, Siegler M, Whitington PF, et al. Ethics of liver transplantation with living donors. N Engl J Med 1989; 321:620.
31. Malago M, Rogiers X, Burdelski M, Broelsch CE. Living related liver transplantation: 36 cases at the University of Hamburg. Transplant Proc 1994; 26:3620.
32. Otte JB. Is it right to develop living related liver transplantation? Do reduced and split livers not suffice to cover the needs? Transpl Int 1995; 8:69.
33. Ozawa K, Uemoto S, Tanaka K, et al. An appraisal of pediatric liver transplantation from living relatives. Initial clinical experiences in 20 pediatric liver transplantations from living relatives as donors. Ann Surg 1992:216:547.
34. Strong RW, Lynch SV, Ong TH, Matsunami H, Koido Y, Balderson GA. Successful liver transplantation from a living donor to her son. N Engl J Med 1990; 322:1505.
35. Otte JB. Donor complications and outcomes in live-liver transplantation. Transplantation 2003; 75:1625.
36. Otte JB, Rosati, Janssen M. Parental experience with live-related donor liver transplantation. Pediatr Transplant 2004; 8:317
37. Surman OS. The ethics of partial-liver donation. N Engl J Med 2002; 346:1038.
38. Strong R, Ong TH, Pillay P, Wall D, Balderson G, Lynch S. A new method of segmental orthotopic liver transplantation in children. Surgery 1988; 104:104.
39. Ringe B, Pichlmayr R, Burdelski M. A new technique of hepatic vein reconstruction in partial liver transplantation. Transpl Int 1988; 1:30.
40. Emond JC, Heffron TG, Whitington PF, Broelsch CE. Reconstruction of the hepatic vein in reduced size hepatic transplantation. Surg Gynecol Obstet 1993; 176:11.
41. Tan KC, Yandza T, de Hemptinne B, Clapuyt P, Claus D, Otte JB. Hepatic artery thrombosis in pediatric liver transplantation. J Pediatr Surg 1988; 23:927.
42. Stevens LH, Emond JC, Piper JB, et al. Hepatic artery thrombosis in infants. A comparison of whole livers, reduced-size grafts, and grafts from living-related donors. Transplantation 1992; 53:396.
43. Hatano E, Terajima H, Yabe S, et al. Hepatic artery thrombosis in living related liver transplantation. Transplantation 1997; 64:1443.
44. Chardot C, Herrera JM, Debray D, et al. Portal vein complications after liver transplantation for biliary atresia. Liver Transpl Surg 1997; 3:351.
45. de Ville de Goyet J, Gibbs P, Clapuyt P, Reding R, Sokal EM, Otte JB. Original extrahilar approach for hepatic portal revascularization and relief of extrahepatic portal hypertension related to later portal vein thrombosis after pediatric liver transplantation. Long term results. Transplantation 1996; 62:71.
46. Egawa H, Inomata Y, Uemoto S, et al. Biliary anastomotic complications in 400 living related liver transplantations. World J Surg 2001; 25:1300.
47. Sanchez-Urdazpal L, Gores GJ, Ward EM, et al. Ischemic-type biliary complications after orthotopic liver transplantation. Hepatology 1992;,16:49.
48. Schwarzenberg SJ, Sharp HL, Payne WD, et al. Biliary stricture in living-related donor liver transplantation: management with balloon dilation. Pediatr Transplant 2002; 6:132.
49. Goulet OJ, de Ville de Goyet J, Otte JB, Ricour C. Preoperative nutritional evaluation and support for liver transplantation in children. Transplant Proc 1987; 19:3249.
50. Sokal E. Les acides aminés branchés dans l'alimentation des cholestases néonatales et leur inclusion dans une diète prête à l'emploi destinée à l'alimentation des cholestases néonatales et infantiles. Mini Acta Soc Belg Pediatr 1996; 28:38.
51. Sokal EM, Van Hoorebeeck N, Van Obbergh L, Otte JB, Buts JP. Upper gastro-intestinal tract bleeding in cirrhotic children candidates for liver transplantation. Eur J Pediatr 1992; 151:326.
52. Otte JB, de Ville de Goyet J, Reding R et al. Sequential treatment of biliary atresia with Kasaiportoenterostomy and liver transplantation: a review. Hepatology 1994; 20:41S.
53. Kasai M, Kimura S, Asakura Y. Surgical treatment of biliary atresia. J Pediatr Surg 1968; 3:665.
54. Van Obbergh L, Carlier M, DeClety SC, et al. Liver transplantation and pulmonary gas exchanges in hypoxemic children. Am Rev Respir Dis 1993; 148:1408.
55. Van Obbergh LJ, Carlier M, DeKock M, Otte JB, Moulin D, Veyckemans F. Hepatopulmonary syndrome and liver transplantation: a review of the peroperative management of seven paediatric cases. Paediatr Anaesth 1998; 59.
56. Hadzic N, Davenport M, Tizzard S, Singer J, Howard ER, Mieli-Vergani G. Long-term survival following Kasaiportoenterostomy: is chronic liver disease inevitable? J Pediatr Gastroenterol Nutr 2003; 37:430.
57. Kurbegov AC, Setchell KD, Haas JE, et al. Biliary diversion for progressive familial intrahepatic cholestasis: improved liver morphology and bile acid profile. Gastroenterology 2003; 1227.
58. Melter M, Rodeck B, Kardorff R, et al. Progressive familial intrahepatic cholestasis: partial biliary diversion normalizes serum lipids and improves growth in noncirrhotic patients. Am J Gastroenterol 2000; 5:3522.
59. Ovaert C, Germeau C, Barrea C, et al. Elevated right ventricular pressures are not a contraindication to liver transplantation in Alagille syndrome. Transplantation 2001; 72:345.
60. Sokal EM, Silva ES, Hermans D, et al. Orthotopic liver transplantation for Crigler-Najjar type I disease in six children. Transplantation 1995; 60:1095.
61. Cochat P, Gaulier JM, Koch Nogueira PC, et al. Combined liver-kidney transplantation in primary hyperoxaluria type 1. Eur J Pediatr 1999; 58[Suppl 2]:S75.
62. Sutcliffe RP, Maguire DD, Muiesan P, et al. Liver transplantation for Wilson's disease: long-term results and quality-of-life assessment. Transplantation 2003; 75:1003.
63. Holme E, Lindstedt S. Nontransplant treatment of tyrosinemia. Clin Liver Dis 2000; 805.
64. Crone J, Moslinger D, Bodamer OA, et al. Reversibility of cirrhotic regenerative liver nodules upon NTBC treatment in a child with tyrosinaemia type I. Acta Paediatr 2003; 625.
65. Sokal EM, Ulla L, Harvengt C, Otte JB. Liver transplantation for familial hypercholesterolemia before the onset of cardiovascular complications. Transplantation 1993; 56:432.
66. Fridell JA, Bond GJ, Mazariegos GV, et al. Liver transplantation in children with cystic fibrosis: a long-term longitudinal review of a single center's experience. J Pediatr Surg 2003; 38:1152.
67. Sokal EM, Sokol R, Cormier V, et al. Liver transplantation in mitochondrial respiratory chain disorders. Eur J Pediatr 1999; 58[Suppl 2]:S81.
68. Faivre L, Houssin D, Valayer J, Brouard J, Hadchouel M, Bernard O. Long-term outcome of liver transplantation in patients with glycogen storage disease type Ia. J Inherit Metab Dis 1999; 723.
69. Lerut JP, Ciccarelli O, Sempoux C, et al. Glycogenosis storage type I diseases and evolutive adenomatosis: an indication for liver transplantation. Transpl Int 2003; 16:879.
70. Sokal EM, Van Hoof F, Alberti D, de Villede Goyet J, de Barsy T, Otte JB. Progressive cardiac failure following orthotopic liver transplantation for type IV glycogenosis. Eur J Pediatr 1992; 51:200.
71. Rosenthal P, Podesta L, Grier R, et al. Failure of liver transplantation to diminish cardiac deposits of amylopectin and leukocyte inclusions in type IV glycogen storage disease. Liver Transpl Surg 1995; 1:373.
72. Selby R, Starzl TE, Yunis E, Brown BI, Kendall RS, Tzakis A. Liver transplantation for type IV glycogen storage disease. N Engl J Med 1991; 324:39.
73. Starzl TE, Demetris AJ, Trucco M, et al. Chimerism after liver transplantation for type IV glycogen storage disease and type 1 Gaucher's disease. N Engl J Med 1993; 328:745.
74. Devictor D, Desplanques L, Debray D, et al. Emergency liver transplantation for fulminant liver failure in infants and children. Hepatology 1992; 16:1156.
75. Pritchard J, Brown J, Shafford E, et al. Cisplatin, doxorubicin, and delayed surgery for childhood hepatoblastoma: a successful approach - results of the first prospective study of the International Society of Pediatric Oncology. J Clin Oncol 2000; 3819.
76. Schnater JM, Aronson DC, Plaschkes J, et al. Surgical view of the treatment of patients with hepatoblastoma: results from the first prospective trial of the International Society of Pediatric Oncology Liver Tumor Study Group. Cancer 2002; 40:1111.
77. Otte JB, Pritchard J, Aronson DC, et al. Liver transplantation for hepatoblastoma: results from the International Society of Pediatric Oncology (SIOP) study. SIOPEL-1 and review of the world experience. Pediatr Blood Cancer 2004; 42:74.
78. Petz W, Spada M, Sonzogni A, et al. Pediatric split liver transplantation using elderly donors. Transplant Proc 2001; 33 1361.
79. McDiarmid SV, Davies DB, Edwards EB. Improved graft survival of pediatric liver recipients transplanted with pediatric-aged liver donors. Transplantation 2000; 70:1283.
80. Sieders E, Peeters PM, TenVergert EM, et al. Graft loss after pediatric liver transplantation. Ann Surg 2002; 235:125.
81. Roberts JP, Hulbert-Shearon TE, Merion RM, Wolfe RA, Port FK. Influence of graft type on outcomes after pediatric liver transplantation. Am J Transplant 2004; 4:373.
82. Reding R, Tri T, Bourdeaux C, et al. Pediatric liver transplantation (LT) with living-related donors (LRD) provides significantly better graft survival than LT with post-mortem donors (PMD): a comparative study in 236 children (abstract). Am J Transplant 2003; 3 [Suppl 5]:306.
83. Emond JC. Living donor liver transplantation in children: what to recommend? Am J Transplant 2004; 4:293.
84. Diem HV, Evrard V, Vinh HT, et al. Pediatric liver transplantation for biliary atresia: results of primary grafts in 328 recipients. Transplantation 2003; 75:1692.
85. Chardot C, Carton M, Spire-Bendelac N, Le Pommelet C, Golmard JL, Auvert B. Prognosis of biliary atresia in the era of liver transplantation: French national study from 1986 to 1996. Hepatology 1999; 30:606.
86. Prachalias AA, Kalife M, Francavilla R, et al. Liver transplantation for alpha-1-antitrypsin deficiency in children. Transpl Int 2000; 13:207.
87. Sokal EM, Antunes H, Beguin C, et al. Early signs and risk factors for the increased incidence of Epstein-Barr virus-related posttransplant lymphoproliferative diseases in pediatric liver transplant recipients treated with tacrolimus. Transplantation 1997; 64:1438.
88. Sokal EM, Caragiozoglou T, Lamy M, Reding R, Otte JB. Epstein-Barr virus serology and Epstein-Barr virus-associated lymphoproliferative disorders in pediatric liver transplant recipients. Transplantation 1993; 56:1394.
89. Smets F, Bodeus M, Goubau P, et al. Characteristics of Epstein-Barr virus primary infection in pediatric liver transplant recipients. J Hepatol 2000; 32:100.
90. Smets F, Latinne D, Bazin H, et al. Ratio between Epstein-Barr viral load and anti-Epstein-Barr virus specific T-cell response as a predictive marker of posttransplantlymphoproliferative disease. Transplantation 2002; 73:1603.
91. Kelly DA, Jara P, Rodeck P, et al. Tacrolimus and steroids versus ciclosporinmicroemulsion, steroids and azathioprine in children undergoing liver transplantation: randomized European multicenter trial. Lancet 2004; 364:1054.
92. Reding R. [Transplantation surgery and immunology: from origins to new paradigms of immune tolerance] Chirurgie et immunologiede transplantation: des originesaux nouveaux paradigmesde la tolerance. Bull Mem Acad R Med Belg 2002; 157:439.
93. Kelly DA, Goddard S. Is there any immunological advantage to living-related donor liver transplantation in pediatric recipients? Pediatr Transplant 2002; 6:364.
94. Toyoki Y, Renz JF, Mudge C, Ascher NL, Roberts JP, Rosenthal P. Allograft rejection in pediatric liver transplantation: comparison between cadaveric and living related donors. Pediatr Transplant 2002; 6:301.
95. Katz SM, Ozaki CF, Monsour HP Jr, et al. Pediatric living-related and cadaveric liver transplantation: a single center experience. Transplant Proc 1994; 26:145.
96. Alonso EM, Piper JB, Echols G, Thistlethwaite JR, WhitingtonPF. Allograft rejection in pediatric recipients of living related liver transplants. Hepatology 1996; 23:40.
97. Reding R, de Ville de Goyet J, Delbeke I, et al. Pediatric liver transplantation with cadaveric or living related donors: comparative results in 90 elective recipients of primary grafts. J Pediatr 1999; 134:280.
98. Gupta P, Hart J, Cronin D, Kelly S, Millis JM, Brady L. Risk factors for chronic rejection after pediatric liver transplantation. Transplantation 2001; 72:1098.
99. Kerkar N, Hadzic N, Davies ET, et al. De-novo autoimmune hepatitis after liver transplantation. Lancet 1998; 351:409.
100. Andries S, Casamayou L, Sempoux C, et al. Posttransplant immune hepatitis in pediatric liver transplant recipients: incidence and maintenance therapy with azathioprine. Transplantation 2001; 72:267.
101. Mazariegos GV, Reyes J, Marino IR, et al. Weaning of immunosuppression in liver transplant recipients Transplantation 1997; 63:243.
102. Fine RN, Alonso EM, Fischel JE, Bucuvalas JC, Enos RA, Gore-Langton RE. Pediatric transplantation of the kidney, liver and heart: summary report. Pediatr Transplant 2004; 8:75.
103. Maes M, Sokal E, Otte JB. Growth factors in children with end-stage liver disease before and after liver transplantation: a review. Pediatr Transplant 1997; 1:171.
104. Renz JF, de Roos M, Rosenthal P, et al. Posttransplantation growth in pediatric liver recipients. Liver Transpl 2001; 7:1040.
105. Lykavieris P, van Mil S, Cresteil D, et al. Progressive familial intrahepatic cholestasis type 1 and extrahepatic features: no catch-up of stature growth, exacerbation of diarrhea, and appearance of liver steatosis after liver transplantation. J Hepatol 2003; 39:447.
106. Codoner-Franch P, Bernard O, Alvarez F. Long-term follow-up of growth in height after successful liver transplantation. J Pediatr 1994; 124: 368.
107. Fine RN, Otte JB, Tejani A. Corticosteroid elimination in pediatric solid organ transplantation. Pediatr Transplant 1998; 2:3.
108. Reding R. Steroid withdrawal in liver transplantation: benefits, risks, and unanswered questions. Transplantation 2000; 70:405.
109. Reding R, Gras J, Sokal E, Otte JB, Davies HF. Steroid-free liver transplantation in children. Lancet 2003; 362:2068.
110. Sarna S, Sipila I, Ronnholm K, Koistinen R, Holmberg C. Recombinant human growth hormone improves growth in children receiving glucocorticoid treatment after liver transplantation. J Clin Endocrinol Metab 1996; 81:1476.
111. Kennard BD, Stewart SM, Phelan-McAuliffe D, et al. Academic outcome in long-term survivors of pediatric liver transplantation. J Dev Behav Pediatr 1999; 20:17.
112. Tornqvist J, Van Broeck N, Finkenauer C, et al. Long-term psychosocial adjustment following pediatric liver transplantation. Pediatr Transplant 1999; 3:115.
113. van Mourik ID, Beath SV, Brook GA, et al. Long-term nutritional and neurodevelopmental outcome of liver transplantation in infants aged less than 12 months. J Pediatr Gastroenterol Nutr 2000; 30:269.
114. Gritti A, DiSarno AM, Comito M, DeVincenzo A, DePaola P, Vajro P. Psychological impact of liver transplantation on children's inner worlds. Pediatr Transplant 2001; 5:37.
115. Schwering KL, Febo-Mandl F, Finkenauer C, Rime B, Hayez JY, Otte JB. Psychological and social adjustment after pediatric liver transplantation as a function of age at surgery and of time elapsed since transplantation. Pediatr Transplant 1997; 1:138.
116. Schulz KH, Hofmann C, Sander K, et al. [Living organ donation vs. cadaveric donation - study of liver transplanted children and their families] Lebendspende vs. Fremdspende - einekatamnestische Studielebertransplantierter Kinderundihrer Familien. Psychother Psychosom Med Psychol 2001; 51:452.
117. Haufroid V, Mourad M, Van Kerckove V, et al. The effect of CYP3A5 and MDR1(ABCB1) polymorphins on cyclosporine and tacrolimus dose requirements and trough blood levels in stable renal transplant patients. Pharmacogenetics 2004; 14:147.
118. Thummel K. A genetic test for immunosuppressant dose selection? Pharmacogenetics 2004; 14:145.
119. Hebert MF, Dowling AL, Gierwatowski C, et al. Association between ABCB1 (multidrug resistance transporter) genotype and post-liver transplantation renal dysfunction in patients receiving calcineurin inhibitors. Pharmacogenetics 2003; 13:661.
120. Diem HV, Sokal EM, Janssen M, Otte JB, Reding R. Steroid withdrawal after pediatric liver transplantation: a long-term follow-up study in 109 recipients. Transplantation 2003; 75:1664.
121. Mazariegos GV, Reyes J, Webber SA, et al. Cytokine gene polymorphisms in children successfully withdrawn from immunosuppression after liver transplantation. Transplantation 2002; 73:1342.
122. Takatsuki M, Uemoto S, Inomata Y, et al. Weaning of immunosuppression in living donor liver transplant recipients. Transplantation 2001; 72:449.
123. Starzl TE, Murase N, Abu-Elmagd K, et al. Tolerogenic immunosuppression for organ transplantation. Lancet 2003; 361:1502.
124. Sokal EM, Smets F, Bourgois A, et al. Hepatocyte transplantation in a 4-year-old girl with peroxisomal biogenesis disease: technique, safety, and metabolic follow-up. Transplantation 2003; 76:735.
125. Allen KJ, Soriano HE. Liver cell transplantation: the road to clinical application. J Lab Clin Med 2001; 138:298.